Madrigal Pharmaceuticals Inc (MDGL): Congress and insider trades
Who in Congress and inside the company traded MDGL, when each filing appeared, and what buying after each one would have earned against the S&P 500.
Key Facts
- Madrigal Pharmaceuticals Inc (MDGL) is a listed stock on NASDAQ.
- 1 member of Congress filed 0 buys and 1 sell of MDGL, the latest published 2023-05-22 (22 May 2023).
- Insiders filed 0 open market buys worth $0 and 5 sells worth $11M, the latest filed 2026-09-11 (11 September 2026).
- Data as of 2026-09-29 (29 September 2026).
Congress trades in MDGL
as of 2023-05-22| Filed | Member | Type | Size | Days to file | 90 day vs S&P |
|---|---|---|---|---|---|
| 22 May 2023 | Daniel S. Goldman (D-NY) | sell | 1Kâ15K | 39 | n/a |
Nothing matches that search.
Insider trades in MDGL
as of 2026-09-11| Filed | Insider | Type | Shares | Price | Value | 90 day vs S&P |
|---|---|---|---|---|---|---|
| 11 Sep 2026 | Sibold William John | sell | 5,221 | $542.39 | $2.8M | n/a |
| 11 Sep 2026 | Sibold William John | sell | 6,362 | $535.59 | $3.4M | n/a |
| 20 Jul 2026 | Sibold William John | sell | 2,500 | $547.30 | $1.4M | n/a |
| 1 Jun 2026 | Soergel David | sell | 1,042 | $495.74 | $517K | n/a |
| 22 May 2026 | Levy Richard S | sell | 5,682 | $515.44 | $2.9M | n/a |
Nothing matches that search.
Related pages
Frequently asked questions
Who has bought MDGL?
0 Congress buys by 1 member and 0 insider buys are on file. The tables on this page list every one.
Did buying MDGL after a disclosure beat the market?
No disclosed buy of this stock has matured 90 days yet. A single stock is a small sample.
Sources: Congressional trades: STOCK Act disclosures, collected from CapitolTrades. Insider trades: SEC Form 4 filings, collected from Finviz. Prices: Yahoo Finance daily adjusted closes. Data as of 2026-09-29 (29 September 2026). About these sources.
Not investment advice. Past disclosed trades do not predict future returns. Disclosures are published late, so the trades shown are ones you could only have copied after the fact. Talk to a licensed adviser before you invest.